WebApr 10, 2024 · Albemarle. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. View Full Analysis. Rewards. Trading at 42.2% below our estimate of its fair value. Revenue is forecast to grow 9.19% per year. Earnings grew by 2075% over the past year. WebApr 11, 2024 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for CTXR stock is $ 7.14 , which predicts an increase of 510.26%. …
CTXR Stock Price Citius Pharmaceuticals Inc. Stock Quote (U.S ...
WebApr 5, 2024 · 1 equities research analysts have issued 1 year target prices for Citius Pharmaceuticals' shares. Their CTXR share price forecasts range from $6.00 to $6.00. … WebCTXR technical analysis Your technical analysis summary for Citius Pharmaceuticals, Inc This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Citius Pharmaceuticals, Inc is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more . 1 minute beardo hair serum benefits
Citius Pharmaceuticals (CTXR) Price To Cash Flow - Zacks.com
WebMar 30, 2024 · Live In Play®. Updated: 30-Mar-23 08:33 ET. CTXR: Citius Pharmaceuticals advances efforts to spin off oncology asset, I/ONTAK, into a standalone public company (1.10) Co announced that Maxim Group LLC will serve as financial advisor to its wholly-owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended formation … WebCTXR Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $5.00 … WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) Nasdaq Listed 1 Earnings Date Add to Portfolio CTXR CTXR REAL TIME CTXR Real-Time Quotes 1D 5D 1M 6M YTD 1Y 5Y MAX Last Five Real-Time... diaphragm\u0027s ij